Business Segment Information

12 Months Ended

Dec. 31, 2019

Note 21—Business Segment Information

The Company has three reportable segments, BSI Life Science, BSI NANO and BEST, as discussed in Note 1 to the consolidated financial statements.

Selected reportable segment information is presented below for the years ended December 31, (dollars in millions):


	2019		2018		2017
Revenue:
BSI Life Science	$	1,244.9	$	1,138.9	$	1,070.9
BSI NANO		632.7		568.1		513.0
BEST		209.9		194.8		191.2
Eliminations (a)		(14.9)		(6.2)		(9.2)
Total revenue	$	2,072.6	$	1,895.6	$	1,765.9
Operating Income:
BSI Life Science	$	290.3	$	244.0	$	212.2
BSI NANO		40.4		48.4		24.3
BEST		16.4		14.5		7.4
Corporate, eliminations and other (b)		(46.2)		(44.5)		(24.4)
Total operating income	$	300.9	$	262.4	$	219.5

(a) Represents product and service revenue between reportable segments.

(b) Represents corporate costs and eliminations not allocated to the reportable segments.

Total assets by segment as of and for the years ended December 31, are as follows (dollars in millions):


	2019		2018
Assets:
BSI Life Science, BSI NANO & Corporate	$	2,711.6	$	2,100.6
BEST		64.6		33.2
Eliminations and other (a)		(4.7)		(5.2)
Total assets	$	2,771.5	$	2,128.6

(a) Assets not allocated to the reportable segments and eliminations of intercompany transactions.

The Company is unable, without unreasonable effort or expense to disclose the amount of total assets by BSI Life Science and BSI NANO Segments as well as the Corporate function and further, the Company’s chief operating decision maker does not receive any asset information by operating segment.

Total capital expenditures and depreciation and amortization by segment are presented below for the years ended December 31, (dollars in millions):


	2019		2018		2017
Capital Expenditures:
BSI Life Science	$	44.4	$	27.6	$	22.7
BSI NANO		18.5		11.6		10.9
Corporate		4.7		3.6		4.9
BEST		5.4		6.4		5.2
Total capital expenditures	$	73.0	$	49.2	$	43.7

Depreciation and Amortization:
BSI Life Science	$	30.5	$	24.0	$	22.8
BSI NANO		35.9		32.2		34.0
Corporate		3.8		4.0		3.0
BEST		5.4		4.7		4.1
Total depreciation and amortization	$	75.6	$	64.9	$	63.9

Revenue and long-lived assets (including property, plant and equipment, net and operating lease right of use assets) by geographical area as of and for the year ended December 31, are as follows (dollars in millions):


	2019		2018		2017
Revenue:
United States	$	529.8	$	489.4	$	434.7
Germany		213.6		201.1		200.2
Rest of Europe		505.2		500.2		465.0
Asia Pacific		651.0		549.2		514.8
Other		173.0		155.7		151.2
Total revenue	$	2,072.6	$	1,895.6	$	1,765.9


	2019		2018		2017
Long-lived assets
United States	$	53.2	$	44.1	$	46.2
Germany		175.1		137.0		140.9
Rest of Europe		118.3		78.7		71.9
Asia Pacific		16.4		6.3		5.4
Other		8.7		4.5		2.1
Total long-lived assets	$	371.7	$	270.6	$	266.5